JP2023536921A5 - - Google Patents
Info
- Publication number
- JP2023536921A5 JP2023536921A5 JP2023507620A JP2023507620A JP2023536921A5 JP 2023536921 A5 JP2023536921 A5 JP 2023536921A5 JP 2023507620 A JP2023507620 A JP 2023507620A JP 2023507620 A JP2023507620 A JP 2023507620A JP 2023536921 A5 JP2023536921 A5 JP 2023536921A5
- Authority
- JP
- Japan
- Prior art keywords
- cardiomyopathy
- seq
- syndrome
- nucleic acid
- heart failure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063061342P | 2020-08-05 | 2020-08-05 | |
| US63/061,342 | 2020-08-05 | ||
| US202163214119P | 2021-06-23 | 2021-06-23 | |
| US63/214,119 | 2021-06-23 | ||
| PCT/US2021/044650 WO2022031914A2 (en) | 2020-08-05 | 2021-08-05 | Methods of treating cardiac disorders and congestive heart failure and administering aav vectors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023536921A JP2023536921A (ja) | 2023-08-30 |
| JP2023536921A5 true JP2023536921A5 (https=) | 2024-08-13 |
Family
ID=80120133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023507620A Pending JP2023536921A (ja) | 2020-08-05 | 2021-08-05 | 心障害およびうっ血性心不全を処置する方法ならびにａａｖベクターを投与する方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230340528A1 (https=) |
| EP (1) | EP4192580A4 (https=) |
| JP (1) | JP2023536921A (https=) |
| CN (1) | CN116406297A (https=) |
| AU (1) | AU2021320244A1 (https=) |
| CA (1) | CA3188398A1 (https=) |
| IL (1) | IL300367A (https=) |
| WO (1) | WO2022031914A2 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3947700A4 (en) | 2019-04-01 | 2023-01-04 | Tenaya Therapeutics, Inc. | Adeno-associated virus with engineered capsid |
| BR112023006305A2 (pt) | 2020-10-09 | 2023-05-09 | Tenaya Therapeutics Inc | Métodos e composições de terapia gênica com placofilina-2 |
| AU2022297795A1 (en) * | 2021-06-23 | 2024-01-04 | AskBio Inc. | Regulatory nucleic acid sequences |
| WO2023178338A2 (en) * | 2022-03-18 | 2023-09-21 | University Of Florida Research Foundation, Incorporated | Methods and compositions for treating tmem43 related cardiomyopathy with a viral vector |
| JP2025512405A (ja) * | 2022-04-11 | 2025-04-17 | テナヤ セラピューティクス， インコーポレイテッド | プラコフィリン２遺伝子治療の処置の方法 |
| CN116256523B (zh) * | 2023-02-02 | 2023-09-12 | 香港大学深圳医院 | 生物标志物在制备用于糖尿病患者HFpEF检测试剂中的应用 |
| IL322735A (en) * | 2023-02-13 | 2025-10-01 | Astrazeneca Ireland Ltd | Nucleic acids encoding BCL2-associated athenogen 3 (BAG3) for gene therapy |
| CN116644347B (zh) * | 2023-05-23 | 2025-11-28 | 珠海市康利莱医疗器械有限公司 | 一种用于风湿性瓣膜病的血清差异多肽检测系统 |
| EP4719440A1 (en) * | 2023-06-01 | 2026-04-08 | Alkahest, Inc. | Compositions of blood plasma fractions and blood plasma subfractions and their use in treatment of disease |
| TW202525313A (zh) * | 2023-09-06 | 2025-07-01 | 瑞士商迪納柯公司 | 用ａａｖ基因治療載體及治療調配物治療肥厚性心肌病之方法 |
| WO2025259575A1 (en) * | 2024-06-10 | 2025-12-18 | Asklepios Biopharmaceutical, Inc. | Methods and compositions for treatment of duchenne muscular dystrophy |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101056539B (zh) * | 2004-09-09 | 2012-12-12 | 综合医院公司 | 调节心脏细胞中的磷酸酶活性 |
| BRPI0912559A2 (pt) * | 2008-05-16 | 2015-10-13 | Corthera Inc | método de tratar insuficiência cardíaca crônica |
| EP4081643A1 (en) * | 2019-12-24 | 2022-11-02 | Asklepios Biopharmaceutical, Inc. | Regulatory nucleic acid sequences |
-
2021
- 2021-08-05 EP EP21853948.4A patent/EP4192580A4/en active Pending
- 2021-08-05 US US18/019,421 patent/US20230340528A1/en active Pending
- 2021-08-05 CA CA3188398A patent/CA3188398A1/en active Pending
- 2021-08-05 WO PCT/US2021/044650 patent/WO2022031914A2/en not_active Ceased
- 2021-08-05 CN CN202180068345.9A patent/CN116406297A/zh active Pending
- 2021-08-05 JP JP2023507620A patent/JP2023536921A/ja active Pending
- 2021-08-05 IL IL300367A patent/IL300367A/en unknown
- 2021-08-05 AU AU2021320244A patent/AU2021320244A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023536921A5 (https=) | ||
| US20240390519A1 (en) | Plakophilin-2 (pkp2) gene therapy using aav vector | |
| US11344608B2 (en) | Factor IX gene therapy | |
| TWI878204B (zh) | 腺相關病毒載體遞送肌肉特異性微小肌縮蛋白以治療肌肉萎縮症 | |
| JP2023538519A5 (https=) | ||
| US12151001B2 (en) | Optimized expression cassettes for gene therapy | |
| US12564647B2 (en) | Optimized expression cassettes for gene therapy | |
| JP2024523707A5 (https=) | ||
| JP2025512574A5 (https=) | ||
| JP2022520232A5 (https=) | ||
| JP2025512574A (ja) | ＡＡＶベクターを使用するＢ細胞リンパ腫２関連Ａｎｔｈａｎｏｇｅｎｅ ３ （ＢＡＧ３）遺伝子治療 | |
| JP2024546103A5 (https=) | ||
| US20240335566A1 (en) | Troponin c (tnnc1) gene therapy using aav vector | |
| JP2024546103A (ja) | Ａａｖベクターを用いたジャンクトフィリン－２（ｊｐｈ２）遺伝子治療 | |
| JP2024119900A (ja) | 優性遺伝性カテコラミン誘発多形性心室頻拍の治療のための組成物および方法 | |
| JP2022530359A5 (https=) | ||
| CA3213231A1 (en) | Gene therapy for arrhythmogenic right ventricular cardiomyopathy | |
| JP2023536067A5 (https=) | ||
| US20250161483A1 (en) | Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy associated with friedreich ataxia | |
| TW202432835A (zh) | 使用aav載體之斑菲素蛋白-2(pkp2)基因療法 | |
| JP2025508743A5 (https=) | ||
| RU2023105139A (ru) | Генная терапия в отношении плакофилина-2 (pkp2) с применением вектора на основе aav | |
| WO2025253097A1 (en) | Proteins with cardiopreservation activity | |
| TW202525313A (zh) | 用ａａｖ基因治療載體及治療調配物治療肥厚性心肌病之方法 | |
| HK40119830A (zh) | 用於治疗和预防与弗里德赖希共济失调相关的心肌病的方法和药物组合物 |